Inanc N - Search Results

1

Immunoglobulin subtypes predict therapy response to the biologics in patients with rheumatoid arthritis.

Can M, Najip A, Yılmaz N, Inanc N, Yavuz S. Can M, et al. Among authors: inanc n. Rheumatol Int. 2013 Jun;33(6):1455-60. doi: 10.1007/s00296-012-2560-8. Epub 2012 Nov 21. Rheumatol Int. 2013. PMID: 23179259

2

The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.

Gordon RA, Nguyen Y, Foulquier N, Beydon M, Gheita TA, Hajji R, Sahbudin I, Hoi A, Ng WF, Mendonça JA, Wallace DJ, Shea B, Bruyn GA, Goodman SM, Fisher BA, Baldini C, Torralba KD, Bootsma H, Akpek EK, Karakus S, Baer AN, Chakravarty SD, Terslev L, D'Agostino MA, Mariette X, DiRenzo D, Rasmussen A, Papas A, Montoya C, Arends S, Yusof MYM, Pintilie I, Warner BM, Hammitt KM, Strand V, Bouillot C, Tugwell P, Inanc N, Andreu JL, Wahren-Herlenius M, Devauchelle-Pensec V, Shiboski CH, Benyoussef A, Masli S, Lee AYS, Cornec D, Bowman S, Rischmueller M, McCoy SS, Seror R. Gordon RA, et al. Among authors: inanc n. Semin Arthritis Rheum. 2024 Apr;65:152378. doi: 10.1016/j.semarthrit.2024.152378. Epub 2024 Jan 23. Semin Arthritis Rheum. 2024. PMID: 38310657

3

Low serum mannose-binding lectin levels in Behçet's disease.

Inanc N, Birtas E, Yavuz S, Ergun T, Direskeneli H. Inanc N, et al. Adv Exp Med Biol. 2003;528:287-9. doi: 10.1007/0-306-48382-3_58. Adv Exp Med Biol. 2003. PMID: 12918709 No abstract available.

4

Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis.

Tiftikci A, Ozdemir A, Tarcin O, Tarcin O, Inanc N, Sahinoglu S, Direskeneli H, Yavuz S, Uras F, Barut Y. Tiftikci A, et al. Among authors: inanc n. Rheumatol Int. 2006 Jan;26(3):191-4. doi: 10.1007/s00296-004-0546-x. Epub 2005 Jan 12. Rheumatol Int. 2006. PMID: 15645233

5

Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity.

Inanc N, Mumcu G, Birtas E, Elbir Y, Yavuz S, Ergun T, Fresko I, Direskeneli H. Inanc N, et al. J Rheumatol. 2005 Feb;32(2):287-91. J Rheumatol. 2005. PMID: 15693089

6

Oral health related quality of life is affected by disease activity in Behçet's disease.

Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U, Yavuz S, Sur H, Atalay T, Direskeneli H. Mumcu G, et al. Among authors: inanc n. Oral Dis. 2006 Mar;12(2):145-51. doi: 10.1111/j.1601-0825.2005.01173.x. Oral Dis. 2006. PMID: 16476035

7

Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M. Inanc N, et al. Among authors: inanc m. Clin Rheumatol. 2007 Jan;26(1):17-23. doi: 10.1007/s10067-006-0214-5. Epub 2006 Mar 15. Clin Rheumatol. 2007. PMID: 16538391

8

Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.

Inanc N, Direskeneli H. Inanc N, et al. Rheumatol Int. 2006 Nov;27(1):67-71. doi: 10.1007/s00296-006-0165-9. Epub 2006 Aug 2. Rheumatol Int. 2006. PMID: 16896990

9

The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders.

Agirbasli M, Inanc N, Baykan OA, Direskeneli H. Agirbasli M, et al. Among authors: inanc n. Clin Exp Rheumatol. 2006 Sep-Oct;24(5):580-3. Clin Exp Rheumatol. 2006. PMID: 17181930

10

Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis.

Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H. Arman A, et al. Among authors: inanc n. Clin Exp Rheumatol. 2006 Nov-Dec;24(6):643-8. Clin Exp Rheumatol. 2006. PMID: 17207379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page